{"id":505723,"date":"2021-06-23T07:03:31","date_gmt":"2021-06-23T11:03:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/"},"modified":"2021-06-23T07:03:31","modified_gmt":"2021-06-23T11:03:31","slug":"alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/","title":{"rendered":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series<\/b><\/p>\n<p>CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.alnylam.com&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=Alnylam+Pharmaceuticals%2C+Inc.&amp;index=1&amp;md5=0925e36952fa0c2baf162b67f3b8ee4e\">Alnylam Pharmaceuticals, Inc.<\/a> (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 8<sup>th<\/sup> annual series of \u201cRNAi Roundtable\u201d webinars over the coming weeks. The series will offer a range of presentations from Alnylam scientists and program leaders who will review recent progress in many of the Company\u2019s pipeline programs and platform innovations, as well as medical thought leaders who will provide their perspectives on clinical developments and unmet needs in various therapeutic areas. Each event will be webcast live on the Investors section of the Company\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.alnylam.com%2Fevents&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=www.alnylam.com%2Fevents&amp;index=2&amp;md5=628b2d6b1ee7066d0ca04bd9bcffc3b6\">www.alnylam.com\/events<\/a>, and a replay will be posted on the Alnylam website approximately three hours after each event.\n<\/p>\n<p>\nThe 2021 RNAi Roundtable schedule is as follows:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>ALN-AGT, in Development for the Treatment of Hypertension<br \/>\n<br \/><\/b>Wednesday, June 30, 10:00 am ET\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Patisiran and Vutrisiran, in Development for the Treatment of ATTR Amyloidosis<br \/>\n<br \/><\/b>Friday, July 16, 11:00 am ET\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Givosiran, for the Treatment of Acute Hepatic Porphyria<br \/>\n<br \/><\/b>Wednesday, August 4, 1:30 pm ET\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Lumasiran, for the Treatment of Primary Hyperoxaluria Type 1<br \/>\n<br \/><\/b>Thursday, August 19, 9:30 am ET (tentative)\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Liver-Directed RNAi Pipeline Programs<br \/>\n<br \/><\/b>Monday, September 20, 11:00 am ET\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>CNS &amp; Extrahepatic RNAi Pipeline Programs<br \/>\n<br \/><\/b>Friday, October 1, 1:30 pm ET\n<\/li>\n<\/ul>\n<p>\nPlease visit the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alnylam.com%2F2021%2F06%2F23%2Frnai-roundtable-series%2F&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=Capella&amp;index=3&amp;md5=f588fb73f452118a6e6d38d252cce43f\">Capella<\/a> section of our website for the latest information regarding webcast dates.\n<\/p>\n<p><b>About RNAi<\/b><\/p>\n<p>\nRNAi (RNA interference) is a natural cellular process of gene silencing that represents one of the most promising and rapidly advancing frontiers in biology and drug development today. Its discovery has been heralded as \u201ca major scientific breakthrough that happens once every decade or so,\u201d and was recognized with the award of the 2006 Nobel Prize for Physiology or Medicine. By harnessing the natural biological process of RNAi occurring in our cells, a new class of medicines, known as RNAi therapeutics, is now a reality. Small interfering RNA (siRNA), the molecules that mediate RNAi and comprise Alnylam\u2019s RNAi therapeutic platform, function upstream of today\u2019s medicines by potently silencing messenger RNA (mRNA) \u2013 the genetic precursors \u2013 that encode for disease-causing proteins, thus preventing them from being made. This is a revolutionary approach with the potential to transform the care of patients with genetic and other diseases.\n<\/p>\n<p><b>About Alnylam Pharmaceuticals<\/b><\/p>\n<p>\nAlnylam (Nasdaq: ALNY) is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)\/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust RNAi therapeutics platform. Alnylam\u2019s commercial RNAi therapeutic products are ONPATTRO<sup>\u00ae<\/sup> (patisiran), GIVLAARI<sup>\u00ae<\/sup> (givosiran), OXLUMO<sup>\u00ae<\/sup> (lumasiran), and Leqvio<sup>\u00ae<\/sup> (inclisiran) being developed and commercialized by Alnylam\u2019s partner Novartis. Alnylam has a deep pipeline of investigational medicines, including six product candidates that are in late-stage development. Alnylam is executing on its \u201cAlnylam P<sup>5<\/sup>x25\u201d strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA. For more information about our people, science and pipeline, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.alnylam.com&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=www.alnylam.com&amp;index=4&amp;md5=a5a31f88086e47f8898032195ffb5aa7\">www.alnylam.com<\/a> and engage with us on Twitter at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FAlnylam&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=%40Alnylam&amp;index=5&amp;md5=28581812da0f9dbe02e97fc0bea7ba30\">@Alnylam<\/a>, on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Falnylam-pharmaceuticals%2F&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=dce61e661d7e83ee4910cf61448306d9\">LinkedIn<\/a>, or on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Falnylampharma%2F&amp;esheet=52449872&amp;newsitemid=20210623005252&amp;lan=en-US&amp;anchor=Instagram&amp;index=7&amp;md5=f95b9b7375d507363e3fbce2fddd747f\">Instagram<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210623005252\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210623005252\/en\/<\/a><\/span><\/p>\n<p><b>Alnylam Pharmaceuticals, Inc.<br \/>\n<\/b><br \/>Christine Regan Lindenboom<br \/>\n<br \/>(Investors and Media)<br \/>\n<br \/>617-682-4340<\/p>\n<p>Josh Brodsky<br \/>\n<br \/>(Investors)<br \/>\n<br \/>617-551-8276\n<\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Surgery Clinical Trials Other Health Biotechnology General Health Pharmaceutical Health Science Other Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210623005252\/en\/682045\/3\/Alnylam_Corporate_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 8th annual series of \u201cRNAi Roundtable\u201d webinars over the coming weeks. The series will offer a range of presentations from Alnylam scientists and program leaders who will review recent progress in many of the Company\u2019s pipeline programs and platform innovations, as well as medical thought leaders who will provide their perspectives on clinical developments and unmet needs in various therapeutic areas. Each event will be webcast live on the Investors section of the Company\u2019s website at www.alnylam.com\/events, and a replay will be posted on the Alnylam website approximately three hours after &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-505723","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 8th annual series of \u201cRNAi Roundtable\u201d webinars over the coming weeks. The series will offer a range of presentations from Alnylam scientists and program leaders who will review recent progress in many of the Company\u2019s pipeline programs and platform innovations, as well as medical thought leaders who will provide their perspectives on clinical developments and unmet needs in various therapeutic areas. Each event will be webcast live on the Investors section of the Company\u2019s website at www.alnylam.com\/events, and a replay will be posted on the Alnylam website approximately three hours after &hellip; Continue reading &quot;Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-23T11:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series\",\"datePublished\":\"2021-06-23T11:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/\"},\"wordCount\":634,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/\",\"name\":\"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-06-23T11:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/","og_locale":"en_US","og_type":"article","og_title":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series - Market Newsdesk","og_description":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 8th annual series of \u201cRNAi Roundtable\u201d webinars over the coming weeks. The series will offer a range of presentations from Alnylam scientists and program leaders who will review recent progress in many of the Company\u2019s pipeline programs and platform innovations, as well as medical thought leaders who will provide their perspectives on clinical developments and unmet needs in various therapeutic areas. Each event will be webcast live on the Investors section of the Company\u2019s website at www.alnylam.com\/events, and a replay will be posted on the Alnylam website approximately three hours after &hellip; Continue reading \"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-23T11:03:31+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series","datePublished":"2021-06-23T11:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/"},"wordCount":634,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/","name":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-06-23T11:03:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210623005252r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alnylam-to-host-eighth-annual-rnai-roundtable-webcast-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alnylam to Host Eighth Annual \u201cRNAi Roundtable\u201d Webcast Series"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=505723"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505723\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=505723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=505723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=505723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}